Bulletin of the World Health Organization

Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV

Anand A Date, Marco Vitoria, Reuben Granich, Mazuwa Banda, Mayada Youssef Fox & Charlie Gilks

Volume 88, Number 4, April 2010, 253-259

Table 1. Development and implementation of policies for co-trimoxazole prophylaxis and isoniazid preventive therapy in World Health Organization regions, 2007

Region Countries receiving survey Countries responding to survey
Countries with CTXp policy
Countries with nationwide implementation of CXTp policya
Countries with IPT policy
Countries with nationwide implementation of IPT policya
Respondent countries
No. No. % No. % No. % No. % No. %
African Region 31 17 55 16 94 11 69 8 47 1 13 Angola, Botswana, Central African Republic, Côte d'Ivoire, Ethiopia, Ghana, Lesotho, Malawi, Mozambique, Nigeria, Rwanda, South Africa, Swaziland, Uganda, United Republic of Tanzania, Zambia, Zimbabwe
Region of the Americas 10 6 60 6 100 4 67 5 83 2 40 Bahamas, Brazil, Colombia, Guyana, Haiti, Trinidad and Tobago
Eastern Mediterranean Region 5 3 60 3 100 2 67 1 33 1 100 Iran, Somalia, Sudan
European Region 11 7 64 6 86 3 50 5 71 2 40 Armenia, Kyrgyzstan, Republic of Moldova, Russian Federation, Tajikistan, The former Yugoslav Republic of Macedonia, Ukraine
South-East Asia Region 5 4 80 4 100 2 50 2 50 0 0 India, Indonesia, Nepal, Thailand
Western Pacific Region 7 4 57 3 75 3 100 0 0 0 0 Cambodia, China, Philippines, Viet Nam
Total 69 41 59 38 93 25 66 21 51 6 28 All countries

CTXp, co-trimoxazole prophylaxis; ITP, isoniazid preventive therapy.
a
Countries providing co-trimoxazole prophylaxis and isoniazid preventive therapy to people living with HIV in all the regions and districts in the country were considered to have achieved nationwide implementation.

[an error occurred while processing this directive]